In lung adenocarcinoma and pancreatic cancer cell lines, curcumin reduces the activity and expression of COX-2, EGFR, and ERK1/2 in a dose-dependent manner, which results in the inhibition of cell survival and the promotion of apoptosis [81]. Here, PTGS2 is linked to familial pancreatic carcinoma.